Tag: Hepatitis B

China Deal on Potential Hep B Cure

Pharmaceutical giant GSK has announced that it has entered into an exclusive collaboration with the Hong Kong-based pharma company Sino Biopharmaceutical to sell in mainland China, a chronic hepatitis B…

Everyone, Everywhere, Right Now!

The World Hepatitis Alliance (WHA) has declared hepatitis a global health emergency. “Hepatitis is an epidemic out of control,” said WHA Chief Executive Officer, Cary James. “It is the only…

Elimination –Urgent Global Action Needed

Urgent scale-up of global action is needed if the world is to meet its target of eliminating viral hepatitis by 2030. This was the clear message from the World Health…

Point-of-Care Testing: The future of hep B care

A clinical trial led by the Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way…

Hepatitis B in Europe: A Persistent Problem

Chronic hepatitis B is substantially prevalent across Europe, affecting an estimated 0.7 per cent of the population in the region in 2022, according to a new study published in Eurosurveillance. While this…

Child vaccination rates falling fast, with some regions barely reaching 80 per cent

By Peter Breadon, Grattan Institute and Mia Jessurun, Grattan Institute Child vaccination has been one of Australia’s biggest success stories. Before the COVID pandemic, we hit the national target of…

New Australian Hepatitis Strategies Released

Australia has taken a significant step in its commitment to ending hepatitis B and C as public health challenges, with the launch of the Fourth National Hepatitis B Strategy 2025–2030 and…

Can I donate blood if I have hepatitis?

This article was originally published by Hepatitis NSW and is republished with permission. If you’ve ever had hepatitis, it might mean you can’t donate blood. Your eligibility to donate blood…

Can the Hepatitis B Virus’s Genetic Diversity Predict its Curability?

Scientists at Melbourne’s Doherty Institute are asking, “What if there was a way to predict which patients are more likely to achieve functional cure of chronic hepatitis B virus infection?”…

Wait! It’s here…

Check out Hepatitis SA's collection of engaging, easy to understand resources about children and hepatitis... including some by and for children.

How Hepatitis B Became a Political Football

The illness and the damage in lives that will come from abandoning the hepatitis B birth dose vaccine is hard to overstate.

In Our Library: February 2026 Highlights

New additions to our Library: The healthy liver pantry, fatty liver disease, hepatitis and mental health, and more...

Hepatitis D Basics

There are five main hepatitis viruses, helpfully named A, B, C, D and E. The hepatitis D virus (HDV)—sometimes known as hepatitis delta—is relatively little-known because it can only live…

National Apology Day 2026

The Federal Government has committed $1.8 million over three years (starting in 2026) to continue the Hepatitis B Partnership Approach to Sustainably Eliminating Chronic Hepatitis B Project in the NT.…

Closing the Gap in Practice

A widely-acclaimed community-led Northern Territory health program which closed the gap for hepatitis B is calling for ongoing support for screening, treatment pathways and workforce capacity building, so that hard-earned…

Moving On to New Challenges

Jeff Stewart’s career as a nurse has never lacked variety, colour and challenge. He had worked with MSF in South Sudan, Rwanda and Liberia, with Aboriginal health services in Yalata,…

Could New Hepatitis B Drug – Bepirovirsen – Offer a Higher Functional Cure Rate?

At the start of January, pharmaceutical company GSK announced positive results from its two phase-III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B. They claim that bepirovirsen…

‘Shared decision-making’ for childhood vaccines sounds empowering – but it may mean less access for families already stretched thin

Shared decision-making is an approach doctors use when there’s genuinely more than one reasonable choice and the answer depends on what matters most and feels right to the patient.